KIT and neoplasm: Tumor burden within the spleen varied between 40 to 98%, and were purified by positive magnetic selection utilizing anti-cKit, Gr1, and Mac1 (CD11b) antibodies for a more homogenous tumor population (Supplementary Fig. 1A).